News Announcement

Natco Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release

NATCO Pharma Limited launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price starting from MRP INR 1290/-

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan